788 related articles for article (PubMed ID: 33933205)
1. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
Blood Pressure Lowering Treatment Trialists' Collaboration
Lancet; 2021 May; 397(10285):1625-1636. PubMed ID: 33933205
[TBL] [Abstract][Full Text] [Related]
2. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.
Blood Pressure Lowering Treatment Trialists' Collaboration
Lancet; 2021 Sep; 398(10305):1053-1064. PubMed ID: 34461040
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Nazarzadeh M; Bidel Z; Canoy D; Copland E; Bennett DA; Dehghan A; Davey Smith G; Holman RR; Woodward M; Gupta A; Adler AI; Wamil M; Sattar N; Cushman WC; McManus RJ; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
Lancet Diabetes Endocrinol; 2022 Sep; 10(9):645-654. PubMed ID: 35878651
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Nazarzadeh M; Bidel Z; Canoy D; Copland E; Wamil M; Majert J; Smith Byrne K; Sundström J; Teo K; Davis BR; Chalmers J; Pepine CJ; Dehghan A; Bennett DA; Smith GD; Rahimi K;
Lancet; 2021 Nov; 398(10313):1803-1810. PubMed ID: 34774144
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
Ettehad D; Emdin CA; Kiran A; Anderson SG; Callender T; Emberson J; Chalmers J; Rodgers A; Rahimi K
Lancet; 2016 Mar; 387(10022):957-967. PubMed ID: 26724178
[TBL] [Abstract][Full Text] [Related]
7. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
[TBL] [Abstract][Full Text] [Related]
8. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S
Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695
[TBL] [Abstract][Full Text] [Related]
9. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.
Law MR; Morris JK; Wald NJ
BMJ; 2009 May; 338():b1665. PubMed ID: 19454737
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal of antihypertensive drugs in older people.
Reeve E; Jordan V; Thompson W; Sawan M; Todd A; Gammie TM; Hopper I; Hilmer SN; Gnjidic D
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012572. PubMed ID: 32519776
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial.
He J; Ouyang N; Guo X; Sun G; Li Z; Mu J; Wang DW; Qiao L; Xing L; Ren G; Zhao C; Yang R; Yuan Z; Wang C; Shi C; Liu S; Miao W; Li G; Chen CS; Sun Y;
Lancet; 2023 Mar; 401(10380):928-938. PubMed ID: 36871573
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
Schmucker C; Eisele-Metzger A; Meerpohl JJ; Lehane C; Kuellenberg de Gaudry D; Lohner S; Schwingshackl L
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013556. PubMed ID: 35199850
[TBL] [Abstract][Full Text] [Related]
14. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials.
Oikonomou EK; Spatz ES; Suchard MA; Khera R
Lancet Digit Health; 2022 Nov; 4(11):e796-e805. PubMed ID: 36307193
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure targets in adults with hypertension.
Arguedas JA; Leiva V; Wright JM
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004349. PubMed ID: 33332584
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC; Gorricho J; Garjón J; Celaya MC; Erviti J; Leache L
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010315. PubMed ID: 32905623
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.
; Ninomiya T; Perkovic V; Turnbull F; Neal B; Barzi F; Cass A; Baigent C; Chalmers J; Li N; Woodward M; MacMahon S
BMJ; 2013 Oct; 347():f5680. PubMed ID: 24092942
[TBL] [Abstract][Full Text] [Related]
19. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.
Brunström M; Carlberg B
JAMA Intern Med; 2018 Jan; 178(1):28-36. PubMed ID: 29131895
[TBL] [Abstract][Full Text] [Related]
20. Effects of intensive blood-pressure control in type 2 diabetes mellitus.
; Cushman WC; Evans GW; Byington RP; Goff DC; Grimm RH; Cutler JA; Simons-Morton DG; Basile JN; Corson MA; Probstfield JL; Katz L; Peterson KA; Friedewald WT; Buse JB; Bigger JT; Gerstein HC; Ismail-Beigi F
N Engl J Med; 2010 Apr; 362(17):1575-85. PubMed ID: 20228401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
